601 related articles for article (PubMed ID: 26479312)
21. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers.
Wong CC; Li W; Chan B; Yu J
Semin Cancer Biol; 2019 Apr; 55():90-105. PubMed ID: 29665409
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities.
Sandoval J; Peiró-Chova L; Pallardó FV; García-Giménez JL
Expert Rev Mol Diagn; 2013 Jun; 13(5):457-71. PubMed ID: 23782253
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic mechanisms in endometrial cancer.
Stampoliou A; Arapantoni-Dadioti P; Pavlakis K
J BUON; 2016; 21(2):301-6. PubMed ID: 27273937
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic biomarkers in urological tumors: A systematic review.
Jerónimo C; Henrique R
Cancer Lett; 2014 Jan; 342(2):264-74. PubMed ID: 22198482
[TBL] [Abstract][Full Text] [Related]
25. Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics.
Laskar RS; Ghosh SK; Talukdar FR
Mol Carcinog; 2015 Dec; 54(12):1786-95. PubMed ID: 25418895
[TBL] [Abstract][Full Text] [Related]
26. The value of epigenetic biomarkers in breast cancer.
Parrella P
Biomark Med; 2018 Sep; 12(9):937-940. PubMed ID: 30041537
[No Abstract] [Full Text] [Related]
27. DNA methylation based biomarkers in colorectal cancer: A systematic review.
Lam K; Pan K; Linnekamp JF; Medema JP; Kandimalla R
Biochim Biophys Acta; 2016 Aug; 1866(1):106-20. PubMed ID: 27385266
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic biomarkers in cancer epidemiology.
Verma M
Methods Mol Biol; 2012; 863():467-80. PubMed ID: 22359311
[TBL] [Abstract][Full Text] [Related]
29. Epigenetics and Precision Oncology.
Werner RJ; Kelly AD; Issa JJ
Cancer J; 2017; 23(5):262-269. PubMed ID: 28926426
[TBL] [Abstract][Full Text] [Related]
30. Beyond the island: epigenetic biomarkers of colorectal and prostate cancer.
Savio AJ; Bapat B
Methods Mol Biol; 2015; 1238():103-24. PubMed ID: 25421657
[TBL] [Abstract][Full Text] [Related]
31. Compendium of aberrant DNA methylation and histone modifications in cancer.
Hattori N; Ushijima T
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):3-9. PubMed ID: 25194808
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation biomarkers and their utility for solid cancer diagnostics.
Heichman KA; Warren JD
Clin Chem Lab Med; 2012 Oct; 50(10):1707-21. PubMed ID: 23089699
[TBL] [Abstract][Full Text] [Related]
33. Tissue and Cell-Free DNA-Based Epigenomic Approaches for Cancer Detection.
Leal A; Sidransky D; Brait M
Clin Chem; 2020 Jan; 66(1):105-116. PubMed ID: 31843869
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic and epitranscriptomic changes in colorectal cancer: Diagnostic, prognostic, and treatment implications.
Porcellini E; Laprovitera N; Riefolo M; Ravaioli M; Garajova I; Ferracin M
Cancer Lett; 2018 Apr; 419():84-95. PubMed ID: 29360561
[TBL] [Abstract][Full Text] [Related]
35. Cancer epigenetics: an introduction.
Kanwal R; Gupta K; Gupta S
Methods Mol Biol; 2015; 1238():3-25. PubMed ID: 25421652
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic biomarkers in prostate cancer: Current and future uses.
Chiam K; Ricciardelli C; Bianco-Miotto T
Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
[TBL] [Abstract][Full Text] [Related]
37. DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status.
Arai E; Kanai Y
Epigenomics; 2010 Jun; 2(3):467-81. PubMed ID: 22121905
[TBL] [Abstract][Full Text] [Related]
38. Aberrantly Methylated cfDNA in Body Fluids as a Promising Diagnostic Tool for Early Detection of Breast Cancer.
Stastny I; Zubor P; Kajo K; Kubatka P; Golubnitschaja O; Dankova Z
Clin Breast Cancer; 2020 Dec; 20(6):e711-e722. PubMed ID: 32792225
[TBL] [Abstract][Full Text] [Related]
39. Aberrant methylation patterns in cancer: a clinical view.
Paska AV; Hudler P
Biochem Med (Zagreb); 2015; 25(2):161-76. PubMed ID: 26110029
[TBL] [Abstract][Full Text] [Related]
40. Micromarkers 2.0: an update on the role of microRNAs in cancer diagnosis and prognosis.
Ferracin M; Negrini M
Expert Rev Mol Diagn; 2015; 15(10):1369-81. PubMed ID: 26338209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]